141 related articles for article (PubMed ID: 29778306)
1. Proton pump inhibitors prescriptions in France: Main trends from 2006 to 2016 on French health insurance database.
Boucherie Q; Rouby F; Frankel D; Roll P; Micallef J
Therapie; 2018 Oct; 73(5):385-388. PubMed ID: 29778306
[TBL] [Abstract][Full Text] [Related]
2. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R
Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548
[TBL] [Abstract][Full Text] [Related]
3. Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region.
Conte C; Bourrel R; Despas F; Lapeyre-Mestre M
Fundam Clin Pharmacol; 2019 Jun; 33(3):327-338. PubMed ID: 30625254
[TBL] [Abstract][Full Text] [Related]
4. [Validity of proton pump inhibitors' prescriptions in a department of internal medicine].
Marie I; Moutot A; Tharrasse A; Hellot MF; Robaday S; Hervé F; Lévesque H
Rev Med Interne; 2007 Feb; 28(2):86-93. PubMed ID: 17092611
[TBL] [Abstract][Full Text] [Related]
5. Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system.
Bongue B; Laroche ML; Gutton S; Colvez A; Guéguen R; Moulin JJ; Merle L
Eur J Clin Pharmacol; 2011 Dec; 67(12):1291-9. PubMed ID: 21691806
[TBL] [Abstract][Full Text] [Related]
6. French health insurance databases: What interest for medical research?
Moulis G; Lapeyre-Mestre M; Palmaro A; Pugnet G; Montastruc JL; Sailler L
Rev Med Interne; 2015 Jun; 36(6):411-7. PubMed ID: 25547954
[TBL] [Abstract][Full Text] [Related]
7. Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada.
Tett SE; Sketris I; Cooke C; van Zanten SV; Barozzi N
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):735-43. PubMed ID: 23559528
[TBL] [Abstract][Full Text] [Related]
8. (De)Prescribing of proton pump inhibitors: what has changed in recent years? an observational regional study from the French health insurance database.
Gendre P; Mocquard J; Artarit P; Chaslerie A; Caillet P; Huon JF
BMC Prim Care; 2022 Dec; 23(1):341. PubMed ID: 36582006
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Prescriptions of Proton Pump Inhibitors in France (2009-2019): A Time-Series Analysis of Trends and Practice Guidelines Impact.
Yang S; Trinh NTH; Chalumeau M; Kaguelidou F; Ruemmele FM; Milic D; Lemaitre M; Cohen JF; Taine M
J Pediatr; 2022 Jun; 245():158-164.e4. PubMed ID: 35120983
[TBL] [Abstract][Full Text] [Related]
10. [Survey of the prescriptions of proton pump inhibitors in patients admitted in an internal medicine ward: how is the compliance to the French guidelines?].
Sauvaget L; Rolland L; Dabadie S; Desblaches J; Bernard N; Vandenhende MA; Bonnet F; Pédeboscq S; Morlat P
Rev Med Interne; 2015 Oct; 36(10):651-7. PubMed ID: 26051189
[TBL] [Abstract][Full Text] [Related]
11. Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia.
Wu J; Dickinson S; Elgebaly Z; Blogg S; Heaney A; Soo Y; Daniels B; Weekes L
BMC Fam Pract; 2020 May; 21(1):85. PubMed ID: 32386520
[TBL] [Abstract][Full Text] [Related]
12. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.
Bezin J; Duong M; Lassalle R; Droz C; Pariente A; Blin P; Moore N
Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):954-962. PubMed ID: 28544284
[TBL] [Abstract][Full Text] [Related]
13. Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France.
Tuppin P; Rudant J; Constantinou P; Gastaldi-Ménager C; Rachas A; de Roquefeuil L; Maura G; Caillol H; Tajahmady A; Coste J; Gissot C; Weill A; Fagot-Campagna A
Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S149-S167. PubMed ID: 28756037
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of users.
Montastruc F; Bénard-Laribière A; Noize P; Pambrun E; Diaz-Bazin F; Tournier M; Bégaud B; Pariente A
Eur J Clin Pharmacol; 2018 May; 74(5):619-626. PubMed ID: 29307053
[TBL] [Abstract][Full Text] [Related]
15. Appropriate proton pump inhibitors use in elderly outpatients according to recommendations.
Schonheit C; Le Petitcorps H; Pautas É
Geriatr Psychol Neuropsychiatr Vieil; 2016 Dec; 14(4):383-388. PubMed ID: 27694063
[TBL] [Abstract][Full Text] [Related]
16. [Proton pump inhibitors: impact of professional practice evaluation on prescriptions pertinence].
Fuzier R; Maguès JP; Dupuis E; Pomiès S; Segui S; Sénard JM
Ann Fr Anesth Reanim; 2011 Nov; 30(11):814-8. PubMed ID: 21981846
[TBL] [Abstract][Full Text] [Related]
17. Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia.
Bruno C; Pearson SA; Daniels B; Buckley NA; Schaffer A; Zoega H
BMJ Qual Saf; 2020 May; 29(5):365-373. PubMed ID: 31641029
[TBL] [Abstract][Full Text] [Related]
18. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
Luo H; Fan Q; Xiao S; Chen K
BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
[TBL] [Abstract][Full Text] [Related]
19. Usage patterns of paracetamol in France.
Duong M; Gulmez SE; Salvo F; Abouelfath A; Lassalle R; Droz C; Blin P; Moore N
Br J Clin Pharmacol; 2016 Aug; 82(2):498-503. PubMed ID: 27059520
[TBL] [Abstract][Full Text] [Related]
20. The French Pregnancy Cohort: Medication use during pregnancy in the French population.
Bérard A; Abbas-Chorfa F; Kassai B; Vial T; Nguyen KA; Sheehy O; Schott AM
PLoS One; 2019; 14(7):e0219095. PubMed ID: 31314794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
